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Characteristic in vivo binding of IgG and C3 to the 
stratum corneum of psoriatic lesions has been implicated 
as a significant event in the pathogenesis of the disease. 
Immunofluorescent findings of psoriatic lesions are com-
pared with other parakeratotic and nonparakeratotic 
lesions. Parakeratotic lesions studied include verrucae 
vulgares in patients with psoriasis, verrucae vulgares in 
patients without psoriasis, actinic keratoses and lichen 
simplex chronicus. Psoriatic lesions and other paraker-
atotic lesions demonstrate similar immunopathological 
phenomena within the involved stratum corneum: (1) A 
high percentage of the lesions stain positively with one 
or more of the immunoglobulins (lgG, lgM and IgA). (2) 
No predominance of any immunoglobulin class is found. 
(3) The predominant sites of immunoglobulin deposition 
are within the regions of parakeratosis. (4) C3 deposition 
is found in a high percentage of the lesions and is present 
at the sites of immunoglobulin binding. By contrast only 
a small percentage of nonparakeratotic lesions display 
stratum corneum fluorescence. These data are consistent 
with macromolecular leakage through the lesional mi-
crovasculature and high affinity binding of immunoglob-
ulins by parakeratotic stratum corneum. Similar immu-
nofluorescent findings in psoriatic lesions and nonpso-
riatic parakeratotic lesions suggest that immunoglobu-
lin binding in psoriatic lesional stratum corneum is not 
a significant event in the pathogenesis of psoriatic le-
sions. 
Immunopathological phenomena characteristically found in 
psoriatic lesions have been considered to be evidence in support 
of a n immunopathogenesis of psoriasis. In vivo binding of IgG 
(1-3) and C3 [1,3,4] to lesional, but not to normal stratum 
corneum of psoriatic patients has been repeatedly demon-
strated. In vivo binding of IgM and lgA has also been reported 
to occur in psoriatic lesions [1,3]. 
Circulating IgG and lgM antibodies against the intercellular 
antigens of the stratum corneum have been found in the sera of 
normals as well as patients with psoriasis [1,5). In vitro studies 
have demonstrated that these antistratum corneum antibodies 
fix complement [6). The titers of these antibodies do not differ 
significantly between psoriatic serum and normal serum (1, 7). 
Krogh [5) has demonstrated a wide variation in antistratum 
corneum antibody levels in normal adult sera; but for a given 
individual, the titers remain essentially unchanged over time. 
By contrast he found that sera from patients with generalized 
subcorneal blister formation and erythroderma had titers that 
varied inversely with the severity of tne disease process. 
The pattern of IgG deposition within psoriatic lesional stra-
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tum corneum corresponds to the distribution of stratum cor-
neum antigens (1). Eluates of psoriatic scales have been found 
to contain antistratum corneum antibody [8]. Presumably, the 
IgG deposition within lesional psoriatic stratum corneum rep-
resents the in vivo fixation of circulating antistratum corneum 
antibodies to stratum corneum antigen sites in psoriatic scales. 
Beutner et al [9) suggest that in psoriasis, stratum corneum 
antigen becomes abnormally reactive because of exposure or 
activation secondary to epidermal trauma. They then postulate 
that the inflammatory response and the increased mitotic rate 
of the epidermal cells are sequellae to the reactions of antistra-
tum corneum antibodies with abnormally reactive stratum cor-
neum antigens. Kaneko et al [3] have recently shown the 
presence of the secretory component of IgA (slgA) within 
psoriatic lesional stratum corneum. They have speculated that 
slgA might initiate ch emotaxis via the alternate complement 
pathway which in turn could unmask antigenicity of the stra-
tum corneum and lead to an IgG autoantibody reaction. 
As circulating antistratum corneum antibodies are neither 
qualitatively nor quantitatively specific for psoriasis, their sig-
nificance in the pathogenesis of psoriasis must be further ex-
amined. The characteristic fixation in vivo of circulating anti-
bodies to the stratum corneum in psoriatic lesions may merely 
reflect a high affinity binding of t~ese antibodies by parakera-
totic stratum corneum. In this study we have examined a 
variety of parakeratotic and nonpa1·akeratotic lesions for the 
presence of specific stratum corneum fluorescence and the 
relationship of this fluorescence to the underlying disease. 
MATERIALS AND METHODS 
Subjects 
AU biopsies were obtained after the patient gave signed informed 
consent. 
A 3-mm punch biopsy for direct immunofluorescence (di.rect IF) was 
performed on one lesion in each of 44 adult patients with psoriasi 
(Group l) . The lesions biopsied had been present from weeks to years. 
An active psoriatic lesion typica l of those found in each patien t was 
chosen as the site for biopsy. Thirty-six patients were receiving treat-
ment at the time of the study and 8 were not. Therapy was not 
interrupted in any of the patients prior to obtaining a biopsy. 
Control specimens were from fou1· sources: Group 2: 33 nonparaker-
atotic lesions were biopsied on patients without psoriasis during a 3-mo 
period of th is investigation for routine diagnostic immunofluorescence, 
and these lesions were studied for the presence of stratum corneum 
fluorescence (Table 1). Similarly studied were Group 3: 10 verrucae 
vulgares from patients with psoriasis; Group 4: 19 verrucae vulgare~ 
from patients without psoriasis; and Group 5: 10 other paJ·akeratotir 
lesions from patients without psoriasis incuding 7 actinic keratoses and 
3 lesions of lichen simplex chronicus. 
Fluorescein Conjugated Antisera 
Monospecific fluorescein-labeled rabbit antisera to human IgG, lgM, 
and lgA were obtained from Behring Diagnostics, American Hoechst 
Pharmaceuticals, Sommerville, New Jersey (Table II). Fluorescein 
conjugated rabbit anti-human C3 antibody was obtained from Hyland 
Division, Travenol Laboratories, Costa Mesa, California (Table ll). 
Antibody specificity was confirmed by immunoprecipi tation duriJ1g 
conjugate preparation. Conjugate dilutions were arrived at by stainiJtg 
positive control skin specimens at serial dilutions to maximize specific 
staining and minimize nonspecific staining. 
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TABLE I. Nonparaheratotic lesions in patients without psoriasis 
Cl inical diagnosis N o. of Patients 
Alop ecia, NOS 
Dermat itis, NOS 
Dermatitis herpetiformis 
Erythema annulare centrifugum 
Eryth e ma multiforme 
Fixed drug eruption 
Gran uloma, NOS 
Lichen planus 
Lupu s erythematosus 
Discoid 
Systemic 
Lymphocytoma cutis 
Mixed connective tissue disease 
Mycosis fungoides 
Vasculitis 
1 
1 
4 
1 
2 
1 
1 
3 
3 
8 
1 
1 
1 
5 
TABLE II. Characteristics of FTC-protein conjugates 
Conjugate Molar F/ P Antibody Working 
ratio unitage" dilution 
Rabbit a ntihuman lgG, y- 2.2 4 1:16 
chain specific 
Rabbit antihuman lgM, fL· 2.2 8 1:16 
chain specific 
Rabbit antihuman lgA, a- 2.2 4 1:8 
chain specific 
Rabbit a ntihuman C3 1.9 8 1:16 
u Antibody unitage of the conjugates (lgG, l gM, and lgA) was deter-
mined in a standard gel diffusion test using 1 mg/ ml ant igen versus 
doubling dilutions of the conjugates. For antihuman C3, undiluted 
normal human serum was used as the ant igen source versus doubling 
dilutions of the conjugate. Antibody unitage is defined as the highest 
conjugate dilution that gives a visible line of precipitation [13]. 
Immunofluorescence Assay 
All tissues were freshly frozen or held in transport medium [10] until 
they could be frozen and subsequently sectioned to a thickness of 4 !Lm 
on an A-merican Optical Cryostat at -30°C. Specimens were processed 
according to standard procedures [11). Sections from each lesion were 
incubated for 30 min in moist chambers at room temperature with 
fluorescein-conjugated antisera to human lgG, lgM, IgA, and C3. In-
cubations were term inated wi th a buffered saline rinse and the slides 
were mounted and examined for direct IF staining of the stratum · 
corneulll · 
All IF readings were made with a standard Zeiss 4FL incident 
fluoresce nce microscope ut ilizing a KP500 excitation filter, a 530 nm 
barrier filter and a 12 v, 100 w Halogen ligh t source. 
RESULTS 
Group 1: Psoriatic Lesions 
Direct IF of psoriatic lesions revealed two patterns (1) of 
stratum corneum staining: (a) an intercellular pattern, charac-
terized by parallel linear staining within the stratum corneum 
(Fig 1) and (b) a diffuse pattern, characterized by clumps of 
stain nonuniformly distributed within the stratum corneum 
(Fig 2). Both patterns were seen together in some specimens . . 
Stratum corneum ·fluorescence with one or more of the con-
jugated antisera (anti-IgG, anti-IgM and anti-IgA) was positive 
in 80% of the 44 lesions. Of the 44 lesions, 73% showed IgG, 77% 
IgM and 75% IgA; these data do not support a predominance of 
any immunoglobulin class or classes within psoriatic lesions. C3 
staining of the stratum corneum was present in 61% of the 
lesions (Table III). 
Group 2: Nonparaheratotic Lesions in Patients without 
Psorias is 
Thirty-three nonparakeratotic lesions as outlined in T able I 
were s tudied for the presence of stratum corneum fluorescence. 
Only 15% of the 33 specimens were positive for immunoglobu-
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lins. No specificity of immunoglobulin class was found . C3 
staining was present in only one lesion (Table III). 
Group 3: Verrucae Vulgares in Patients with Psoriasis 
Stratum corneum fluorescence was present in all of the 10 
lesions. Both intercellular and diffuse staining patterns were 
seen. As Fig 3 illustrates, stratum corneum fluorescence in the 
verrucae was found in the tiers of parakeratotic cells as opposed 
to the regions of orthokeratotic hyperkeratosis. One hundred 
percent of the specimens contained IgG, 70% IgM and 60% IgA. 
Seventy percent were positive for C3 (Table III) . 
Group 4: Verrucae Vulgares in Patients without Posoriasis 
Eighteen of the 19 verrucae obtained from nonpsoriatic pa-
tients showed stratum corneum fluorescence with one or more 
of the conjugates. As described above for Group 3, both staining 
pa tterns were seen and the fluorescence was seen in the para-
keratotic tiers as opposed to the regions of orthokeratotic 
hyperkeratosis (Fig 4) . IgG was present in 89%, IgM in 58%, 
IgA in 74% and C3 in 74% (Table III) . 
Group 5: Other Paraheratotic Lesions in Patients without 
Psoriasis 
Ten other parakeratotic lesions (3 lichen simplex c hronicus 
and 7 actinic keratoses) all showed stratum corneum flum·es-
cence with one or more of the conjugates. Both staining patterns 
wel"e seen, and the flum·escence appeal"ed to be localized to the 
regions of parakeratosis (Fig 5). One hundred percent of the 
lesions contained IgG, 80% IgM, 90% IgA and 60% C3 (Table 
III). 
Immunofluorescence Staining of the Stratum Corneum 
The intensity of fluorescence staining was variable. No con-
sistent difference in the intensity of staining was seen with any 
of the conjugates, nor was it seen with any of the kinds of 
lesions examined. An intercellular and/ or diffuse staining pat-
FIG 1. Psoriatic lesional stratum corneum. Anti-lgA. Direct IF, lin-
ear staining pattern (reduced from X 250). 
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tern was seen in each of the positve lesions. Localization of the 
stratum corneum fluorescence appeared to closely correlate 
with the sites of parakeratotic as opposed to orthokeratotic 
hyperkeratosis. 
Statistical Analysis of the Data 
Data was analyzed by comparing each group to psoriatic 
lesions. Tests utilized, included chi square (corrected for conti-
nuity) , Fishers exact test (one-tailed and two-tailed), phi coef-
ficient, tetrachoric correlation and Goodman-Kruskal index of 
predictive association. Only one group (the nonparakeratotic 
group) demonstrated a statistically significant difference from 
psoriatic lesions (Table III). 
The non psoriatic patients with non parakeratotic lesions con-
sistently showed a statistically significant difference with all 
FIG 2. Psoriatic lesional stratum corneum. Anti-IgG. Direct IF, dif-
fuse staining pattern (reduced from X 250). 
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measured variables: presence of immunoglobulins (lgG, M or 
A) , lgG+, IgM+, IgA+, and C3+. X2 showed an association 
with all variables at p < 0.00005 and phi coefficient showed a 
strength of association with all variables at p < 0.0005. 
DISCUSSION 
Beutner et al (9] suggest that in psoriasis stratum corneum 
antigen is exposed or activated by epidermal trauma and that 
an IgG autoantibody response is contributing to the inflam-
matory component of the disease. Kaneko et al (3] have shown 
slgA within psoriatic stratum corneum and have speculated 
that slgA might initiate chemotaxis via the alternate · comple-
ment pathway which in turn could unmask antigenicity of the 
stratum corneum and lead to an IgG autoantibody reaction. 
FIG 3. Verruca vulgaris, patient with psoriasis. Anti-lgG. Direct IF. 
Staining of parakeratotic stratum corneum (reduced from X 250) . 
TABLE III. Direct immunofluorescence results 
Diagnosis 1g (G, MorA} + lg G+ 
l. Psoriatic lesions (44)" 35" (80%)< 32 (73%) 
2. Nonpsoriatic patients- 5 (15%) 3 (9%) 
nonparakeratotic le- l = 28.80" l = 28.29 
sions (33) </> = -0.638'" q> = -0.632 
3. Psoriatic patients-ver- 10 (100%) 10 (100%) 
ruca vulgaris lesions 
(10) 
4. Nonpsoriatic patients- 18 (95%) 17 (89%) 
verruca vulgaris lesions 
(19) 
5. Nonpsoriatic patients- 10 (100%) 10 (100%) 
parakeratotic lesions 
(10) 
"Number of lesions. 
1
' Number of lesions which are positive for stratum corneum flu orescence. 
,. Percent of lesions which are positive for stratum corneum fluorescence. 
"X2 = Chi square corrected for continuity with p < 0.00005, statistically significant. 
• q, = Phi coefficient with p < 0.0005, statistically significant. 
l g M+ lg A+ C3+ 
34 (77%) 33 (75%) 27 (61%) 
4 (12%) 3 (9%) 1 (3%) 
l = 29.47 / = 30.31 l = 25.27 
cJ> = -0.645 cJ> = -0.654 <I> = -0.600 
7 (70%) 6 (60%) 7 (70%) 
11 (58%) 14 (74 %) 14 (74%) 
8 (80%) 9 (90%) 6 (60%) 
March1982 
FIG 4. Verruca vulgaris, patient without psoriasis. Anti-human C3. 
Direct IF. Staining of parakeratotic stratum corneum (reduced from 
X 250). 
FIG 5. Actinic keratosis, patient without psoriasis. Anti-lgG. Direct 
IF. Staining of parakeratotic stratum corneum (reduced fTOm X 250). 
Krogh [5] has shown, however , that antistratum corneum anti-
bodies are not unique to psoriatic patients but a re present in all 
individuals tested. Jablonska eta! [2] have also shown that the 
in vivo deposition of IgG antistratum corneum a ntibody is not 
unique for psoriasis but may be present in other lesions as well. 
Immunopathological da ta in our study reveal evidence for in 
vivo stratum corneum binding of immunoglobulins in a high 
percentage of all parakeratotic lesions in contrast with a low 
percentage binding in nonparakeratotic controls. Psoriatic le-
sions, verrucae occcurring in psoriatics and nonpsoriatics, ac-
tinic keratoses, and lesions of lichen simplex chronicus all 
showed a high percentage of stratum corneum staining with 
IgG, IgM, and IgA. We found no predominance of any of the 
immunoglobulin classes, nor did we find any significant differ -
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ences in staining patterns or staining intensity . Examination of 
non psoriatic parakeratotic lesions showed the predomina nt site 
of immunoglobulin deposition to be within the regions of par-
akeratosis. Beutner et al [1, 7] have shown that in usual cases of 
psoriasis, the titers of a ntistratum corneum antibodies do not 
differ between psoriatic serum and normal serum. In patients 
with generalized subcorneal blister formation and erythro-
derma, Krogh [5] has shown that the titer of a.ntistratum 
corneum antibodies does vary inversely with the severity of the 
disease process. Worm and Rossing [12] have shown an increase 
in microvascular leakage in extensive skin diseases including 
psoriasis. These da ta taken together suggest that the immuno-
pathological phenomena found in psoriatic lesions are the result 
of a macromolecular leakage of inununoglobulins from psoriatic 
microvasculature in combination with a high affinity binding of 
the immunoglobulins in psoriatic parakeratotic stratum cor-
neum. 
Antistratum corneum an tibodies have been shown to fix 
complement in vitro and in vivo in psoriatic lesions [6]. Ow· 
data show evidence for in vivo complement fixation in 61% of 
psoriatic lesions, 60 to 74% of non psoriatic parakeratotic lesions 
and only 3% of non parakeratotic lesions. The site of C3 staining 
as well as the staining pattern and staining intensity were 
similar to that described for immunoglobulin staining. As mi-
croabscesses are not a feature of verrucae, actinic keratoses or 
lesions of lichen simplex chronicus, we conclude that immuno-
globulin deposition and complement activation within lesional 
stratum corneum do not adequately explain the formation of 
characteristic microabscesses in psoriasis. Similarly, although 
psoriasis, verrucae and lichen simplex chronicus display acan-
thosis, the actinic keratoses did not show acanthosis despite the 
ident ical immunopathological phenomena occurring in the stra-
tum corneum of all the lesions. We conclude, t herefore, that 
immunoglobulin deposit ion and complement activation within 
lesional stratum corneum do not adequately explain the char-
acteristic acanthosis seen in psoriatic lesions. Moreover, if im-
munoglobulin binding were a significant pathogenetic feature 
of psoriasis, verrucae which occur in patients with psoriasis and 
which display the same immunopathological features as the 
psoriatic lesions, might be expected to rout inely evolve into 
psoriatic plaques which is not the case. 
For the above reasons, immunoglobulin binding in the stra-
tum corneum of psoriatic lesions may, therefore, not be a 
significant event in the pathogenesis of these lesions. 
The authors wish to thank Liuda Butikas and Charles Motley for 
their technical assistance. 
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